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How embryonic stem cells maintain the potential to differentiate into multiple cell lineages 
is still unclear. In this issue of Cell, Niwa et al. (2005) show that a duel between the tran-
scription factors Oct3/4 and Cdx2 can restrict embryonic stem cells to either embryonic 
or placental fate. The vulnerability of lineage potential to transcriptional perturbation may 
reflect an essential feature of pluripotency.Pluripotency is the capacity of a cell 
to generate all lineages of the devel-
oping mammalian embryo, including 
the germline. This is the unique and 
essential property of the epiblast, a 
population of founder cells located 
within the developing blastocyst. 
These epiblast cells form in conjunc-
tion with the segregation of extra-
embryonic and embryonic lineages 
during the preimplantation phase of 
development (Figure 1). Epiblast cells 
multiply transiently until gastrulation, 
during which they then develop into 
either primordial germ cells or somatic 
progenitor cells. In vitro, the progres-
sion to gastrulation can be interrupted 
and pluripotency sustained indefinitely 
by deriving self-renewing embryonic 
stem (ES) cells. How pluripotency is 
acquired by a subset of cells in the 
embryo and how it is maintained in ES 
cells are questions of intellectual fasci-nation and increasingly of biomedical 
significance. A series of incisive exper-
iments by Niwa and colleagues (2005) 
reported in this issue of Cell provide a 
conceptual framework for considering 
these phenomena.
Niwa et al. (2005) focus attention 
on Oct3/4, a master transcriptional 
organizer of the POU transcription 
factor family. Oct3/4 expression is 
found exclusively in early embryos, the 
germline, and ES cells. In the embryo, 
Oct3/4 is essential to establish pluri-
potency (Nichols et al., 1998). Without 
Oct3/4, inner cells of the blastocyst 
fail to acquire the potential to differ-
entiate into multiple lineages and are 
restricted to the generation of a single 
lineage, the extraembryonic trophec-
toderm, which eventually gives rise to 
the placenta. Furthermore, continuous 
expression of Oct3/4 is required to 
sustain pluripotency. The elimination Cell 123, Deof Oct3/4 from ES cells precipitates 
unidirectional differentiation into troph-
ectoderm (Niwa et al., 2000).
Oct3/4 is thus positioned foremost 
in the hierarchy of transcriptional 
determinants of the pluripotent state 
(Chambers and Smith, 2004). One 
key effect of Oct3/4 is to suppress 
differentiation of embryonic cells into 
trophectoderm. Niwa et al. (2005) 
demonstrate that Oct3/4 achieves this 
by blocking both the expression and 
activity of the homeodomain transcrip-
tion factor Cdx2. First, they observed 
that Cdx2 is rapidly upregulated upon 
elimination of Oct3/4 from mouse ES 
cells. Then they found that forced 
expression of Cdx2 is sufficient to 
induce trophoblast differentiation (Fig-
ure 1, lower panel), reproducing the 
effect of removal of Oct3/4. The gene 
expression changes that accompany 
misexpression of Cdx2 or elimination cember 2, 2005 ©2005 Elsevier Inc. 757
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and Cdx2 Specifies Lineage Potential in 
the Mouse Blastocyst and Embryonic 
Stem Cells
(Upper panel) In the early morula stage embryo, 
antagonistic transcription factors Cdx2 (blue) 
and Oct3/4 (yellow) are uniformly expressed 
(green). With loss of symmetry at the 8–16 cell 
division, this balance is perturbed. Cdx2 is rap-
idly extinguished in the inner cells where Oct3/4 
expression is high (yellow) but progressively be-
comes dominant in the outer layer (aquamarine) 
during the late morula stage, culminating in the 
specification of pluripotent and trophectodermal 
identity, respectively, in the early blastocyst.
(Lower panel) In the late blastocyst, three lin-
eages are determined by distinct transcription 
factors: trophectoderm by Cdx2 (blue), primi-
tive endoderm by Gata-6 (purple), and epiblast 
by Oct3/4 (yellow). Derivative cell lines faith-
fully retain lineage specification (bold arrows). 
However, misexpression of Cdx2 or Gata-6 in 
embryonic stem cells extinguishes pluripotency 
and imposes extraembryonic fates.of Oct3/4 are strikingly similar. Fur-
thermore, introduction of Cdx2 leads 
to downregulation of Oct3/4 expres-
sion, pointing to a reciprocal repres-
sion loop. Consistent with this, Cdx2 
can interfere directly with the posi-
tive transcriptional autoregulation of 
Oct3/4, and Oct3/4 in turn inhibits 
Cdx2 autostimulation. In addition to 
mutual repression of transcription, the 
two proteins appear to bind to one 
another in a complex which neutralizes 
their respective transcriptional activa-
tion effects. This tug-of-war explains 
the finding that overexpression of 
Cdx2 induces differentiation of ES 
cells into trophectoderm and silences 
pluripotent-specific genes even when 
Oct3/4 expression is maintained from 
a transgene.
But is this an artifact of intricate 
genetic manipulations of the mouse ES cell culture system? The question 
is pertinent because trophectoderm 
lineage commitment and segregation 
are implemented in the embryo prior 
to formation of the epiblast; therefore, 
this fate choice would be expected 
to be excluded for ES cells. Indeed, 
trophectoderm differentiation is not 
normally exhibited by mouse ES cells 
in vitro or in mouse chimeric embryos. 
It is therefore important to show that 
cells expressing markers of trophec-
toderm (such as Cdx2) are actually 
part of the trophectoderm lineage. 
To test this, Niwa et al. (2005) engi-
neered mouse ES cells to express a 
form of Cdx2 that can be regulated 
by a hormone and then assayed their 
developmental potential by injecting 
these ES cells into blastocysts. Mouse 
ES cells in which Cdx2 is not induced 
populate the embryo, but not the pla-centa, as expected. In contrast, ES 
cells in which Cdx2 is induced do not 
contribute to the embryo but instead 
colonize the placenta. Importantly, 
these Cdx2 induced cells are morpho-
logically differentiated and integrated 
into the placental cytoarchitecture. 
Thus, they meet stringent criteria for 
both trophectodermal lineage restric-
tion and functional trophoblast diff-
erentiation.
So how do these results relate to 
the mechanism of segregating troph-
ectoderm and establishing pluripo-
tency in the embryo? Cdx2-deficient 
blastocysts are unable to undergo 
implantation into the uterus, which 
indicates defective trophoblast dif-
ferentiation. Oct3/4 and a second key 
pluripotency gene Nanog show ecto-
pic expression in these blastocysts 
(Strumpf et al., 2005) consistent with 
a function of Cdx2 to repress plu-
ripotent gene expression in wild-type 
trophectoderm. How do Cdx2 and 
Oct3/4 normally localize to the outer 
trophectoderm and inner pluripotent 
cell layers, respectively? Niwa et al. 
(2005) found that Cdx2 and Oct3/4 
proteins are transiently coexpressed 
throughout the early embryo (Figure 
1, upper panel). Reciprocal inhibi-
tion of Cdx2 and Oct3/4 activity may 
create a delicately poised see-saw 
between the two factors. A marginal 
shift in balance would result in a rapid 
and inexorable amplification of one 
transcription factor culminating in the 
elimination of the other and the speci-
fication of cell fate (Figure 1, upper 
panel). An initial imbalance between 
the transcription factors might occur 
stochastically, followed by sorting of 
cells to the appropriate tissue loca-
tion. Alternatively, cell polarity or 
cell size could influence the relative 
expression, stability, and asymmet-
ric allocation of Cdx2 and Oct3/4 
between sister cells.
Cells in the mouse embryo cease 
to be identical after compaction (the 
morphological change that blasto-
meres undergo after the third cleav-
age), when changes in cell-cell con-
tacts lead to apicobasal polarization 
and asymmetric divisions from 8 to 16 
cells generate large polarized outer 
cells and small apolar internal cells 
(Johnson and Ziomek, 1981). This 
event and the subsequent differen-
tiation of the outer cells into an epi-
thelium are independent of any duel 
between Cdx2 and Oct3/4 because 
mouse mutants lacking Cdx2 form 
blastocysts. However, the outer cells 
of these blastocysts do not sustain 
epithelial integrity and subsequently 
degenerate. In addition to misexpres-
sion of Oct3/4 and Nanog, Cdx2-defi-
cient outer cells fail to upregulate the 
protein eomesodermin, a T box tran-
scription factor required for functional 
trophoblast differentiation (Strumpf et 
al., 2005). Therefore, the initial alloca-
tion and separation of inner and outer 
lineages is not dependent on Cdx2, 
but in its absence the outer cells are 
unable to differentiate properly. This 
is analogous to the effect of Oct3/4 
deletion on the development of plu-
ripotency in the inner cells (Nichols 
et al., 1998). Overall, the genetic and 
cell biological evidence suggest that 
the outer and inner blastocyst cell 
lineages are established separately 
from specification of trophectodermal 
and pluripotent identity. How cellular 
asymmetry is coupled to differential 
distribution of Cdx2 and Oct3/4 and 
hence to appropriate cell specifica-
tion remains an open question.
Although trophoblast differentiation in the mouse embryo is blocked in the 
absence of Cdx2, Niwa et al. (2005) 
unexpectedly found that Cdx2-defi-
cient ES cells can differentiate into tro-
phoblast-like cells upon elimination of 
Oct3/4. They attribute this to the pro-
tein eomesodermin. Eomesodermin 
is necessary for trophoblast differen-
tiation in vivo and, like Cdx2, appears 
to be both transcriptionally repressed 
and functionally antagonized by 
Oct3/4 in ES cells. The authors show 
that high overexpression of eomeso-
dermin can induce trophoblast-like 
differentiation of ES cells. Placental 
chimeras have not been generated in 
this case, so the evidence is limited 
to morphology and marker expres-
sion, and indeed the differentiation 
appears incomplete. This may be 
because, unlike Cdx2, eomesoder-
min does not inhibit Oct3/4 activity. 
Failure of trophoblast differentiation 
in the cdx2 mutant blastocysts might 
therefore be due to the dominance of 
persistent Oct3/4 over eomesodermin 
in the nascent epithelial cells. This 
can be tested experimentally: if the 
unique and critical function of Cdx2 is 
to eliminate Oct3/4 and thus to liber-
ate eomesodermin, then trophoblast 
differentiation should be restored in 
mutant blastocysts lacking both Cdx2 
and Oct3/4.
The authors propose that resolu-
tion of the conflict between Cdx2 and 
Oct3/4 may be decisive for imbuing 
internal cells of the blastocyst with 
the capacity for pluripotency. But is 
mutual inhibition both necessary and 
sufficient to drive Cdx2 out of the blas-
tocyst inner cells, or is this a second-
ary mechanism to consolidate seg-
regation established by some other 
process? Examination of Oct3/4-defi-
cient blastocysts should be informa-
tive. Inner cells of Oct3/4 mutant blas-
tocysts initially may not be specified to 
follow a trophectodermal fate (Nichols 
et al., 1998). Thus, the question arises 
whether Cdx2 is maintained continu-
ously, consistent with primary repres-
sion by Oct3/4, or is extinguished only 
to reemerge at a later stage.
In mouse ES cells, circumvent-
ing Oct3/4 transcriptional repression 
by forced expression of either Cdx2 
(Figure 1, lower panel) or eomesoder-Cell 123, Demin is sufficient to overcome restric-
tion to a trophectodermal fate. Niwa, 
Fujikura, and colleagues previously 
showed that mouse ES cells could 
be driven into the second extraem-
bryonic lineage (primitive endoderm) 
by misexpression of the transcription 
factors Gata-6 or Gata-4 (Fujikura et 
al., 2002; Figure 1, lower panel). The 
mechanism by which these transcrip-
tion factors are normally blocked in 
ES cells is unknown but may involve 
Nanog and the LIF/Stat3 signaling 
pathway (Chambers and Smith, 2004) 
rather than Oct3/4. However, both 
findings suggest that the pluripotent 
ES cell state may be actively sustained 
by dominant transcriptional and post-
transcriptional regulators rather than 
the chromatin-based epigenetic deter-
mination that is considered critical for 
somatic lineage restriction. Extraem-
bryonic lineages too may be subject to 
epigenetic shutdown because pluripo-
tency is not readily reinstated in troph-
ectoderm or primitive endoderm in 
response to Oct3/4 or Nanog expres-
sion (I. Chambers, T. Kunath, and A.S., 
unpublished data).
A molecular correlate of pluripo-
tency, therefore, may be an inert epi-
genetic machinery, presenting a tabula 
rasa for gene expression. However, 
control of gene expression mediated 
solely by transcription factors is a 
metastable condition, the outcome of 
which could fluctuate in the artificial 
environment of cell culture. Variability 
in mouse ES cell derivation, differen-
tiation of human ES cells into trophec-
toderm without genetic manipulation, 
and expression of Cdx2 rather than 
Oct3/4 in stem cells derived from rat 
blastocysts (Buehr and Smith, 2003) 
all could be explained by subtle strain 
and species differences in the cross-
regulatory capacity of Cdx2 and 
Oct3/4. Conversely, resetting of tran-
scriptional control on a background 
of minimal epigenetic restriction may 
account for reversion of primordial 
germ cells and germline stem cells to 
a pluripotent state (Kanatsu-Shinohara 
et al., 2004). A requirement simply to 
erase programming may underlie the 
relative success in obtaining ES cells 
compared with viable fetuses after 
nuclear transfer from somatic cells cember 2, 2005 ©2005 Elsevier Inc. 759
(Wakayama et al., 2001).
Finally, high efficiency in generat-
ing mice by nuclear transfer from ES 
cells is consistent with the notion that 
the pluripotent epigenome is unpro-
grammed. Indeed, removal of DNA 
methylation does not cripple ES cells, 
although downstream differentiation 
is impaired. If epiblast and ES cells 
are truly unprogrammed, self-renewal 
and pluripotency will withstand loss 
of other epigenetic modifications and 
be sustained only by transcriptional 
regulators. However, reintroduction 
of deleted components may be nec-
essary to rescue disabled machinery 
necessary for cellular differentiation.760 Cell 123, December 2, 2005 ©2005 E
As science progresses, a trail of 
unsolved puzzles and paradoxes is left 
behind along with misfit results that 
can never be fully explained but must 
have some significance. This issue of 
Cell contains a remarkable paper from 
Marcel Méchali’s lab (Lemaitre et al., 
2005) that solves several such mys-
teries at a single stroke. The Mechali 
study addresses the esoteric question 
of why the DNA in nuclei from adult 
somatic cells of the frog replicates 
more slowly than the DNA of sperm 
nuclei does when both are exposed to 
extracts of frog eggs. The difference 
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